Neuromyelitis optica spectrum disorder treatment—current and future prospects
M Waliszewska-Prosół, J Chojdak-Łukasiewicz… - International Journal of …, 2021 - mdpi.com
Neuromyelitis optica (NMO) is an immune-mediated demyelinative disorder of the central
nervous system affecting mainly the optical nerves and the spinal cord. The recurrent course …
nervous system affecting mainly the optical nerves and the spinal cord. The recurrent course …
Management strategies of patients with neuromyelitis optica spectrum disorder during the COVID-19 pandemic era
SM Hamdy, M Abdel-Naseer, HS Shehata… - … and Clinical Risk …, 2020 - Taylor & Francis
Abstract The ongoing coronavirus (COVID-19) pandemic is a global health emergency of
international concern and has affected management plans of many autoimmune disorders …
international concern and has affected management plans of many autoimmune disorders …
Intravenous immunoglobulin treatment for steroid-resistant optic neuritis: a multicenter, double-blind, randomized, controlled phase III study
O Mimura, H Ishikawa, T Kezuka, K Shikishima… - Japanese Journal of …, 2021 - Springer
Purpose To evaluate the efficacy and safety of intravenous “freeze-dried sulfonated human
normal immunoglobulin (GGS)” in patients with steroid-resistant optic neuritis (ON). Study …
normal immunoglobulin (GGS)” in patients with steroid-resistant optic neuritis (ON). Study …
Neuromyelitis optica spectrum disorders: Clinical perspectives, molecular mechanisms, and treatments
S Thangaleela, BS Sivamaruthi, A Radha, P Kesika… - Applied Sciences, 2023 - mdpi.com
Neuromyelitis optica (NMO) is a rare autoimmune inflammatory disorder affecting the central
nervous system (CNS), specifically the optic nerve and the spinal cord, with severe clinical …
nervous system (CNS), specifically the optic nerve and the spinal cord, with severe clinical …
Review on optic neuritis clinical features, diagnosis, and management approach
ZS Al-Kalaif, HG Alzayer, HA Al-Suwat… - …, 2021 - pharmacophorejournal.com
Optic neuritis (ON) is a sight-threatening condition characterized by inflammation of the optic
nerves [1, 2]. The condition is fairly common as lifetime prevalence is 6/10,000 and the mean …
nerves [1, 2]. The condition is fairly common as lifetime prevalence is 6/10,000 and the mean …